Nursing and Health Professions
Hypoglycemia
100%
Continuous Glucose Monitoring
46%
Patient with Type 1 Diabetes
38%
Patient with Type 2 Diabetes
34%
Patient with Diabetes
25%
Pilot Study
25%
Insulin Dependent Diabetes Mellitus
23%
Non Insulin Dependent Diabetes Mellitus
23%
Ward
22%
Systematic Review
21%
Health Service
21%
Insulin Pump
19%
Hemoglobin A1c
16%
Continuous Glucose Monitoring System
12%
Body Mass
12%
Hyperglycemia
12%
Anemia
10%
Hospital
10%
Insulin Infusion
10%
Artificial Pancreas
10%
Total Quality Management
10%
Multiple Drug Dose
10%
Nocturnal Hypoglycemia
10%
Insulin Degludec
10%
Chronic Kidney Failure
10%
Hospital Management
10%
Meta Analysis
10%
Body Weight Change
10%
Glucagon Like Peptide 1 Receptor Agonist
10%
Bariatric Surgery
10%
Endocrinologist
10%
Telemedicine
10%
Longitudinal Analysis
10%
Dipeptidyl Peptidase IV Inhibitor
8%
Clinical Practice
7%
Diabetes Mellitus
7%
Glucose Level
7%
Hospitalization
6%
Antidiabetic Agent
6%
Insulin Treatment
6%
Sodium Glucose Cotransporter 2 Inhibitor
5%
Diabetic Complication
5%
Blood Glucose Monitoring
5%
CINAHL
5%
Infection
5%
Acute Kidney Failure
5%
Adult Respiratory Distress Syndrome
5%
Clinical Outcome
5%
Patient Preference
5%
Disease Management
5%
Medicine and Dentistry
Hypoglycemia
79%
Insulin Dependent Diabetes Mellitus
46%
Patient with Type 1 Diabetes
39%
Glycemic
29%
Insulin Pump
26%
Diabetes
26%
Bariatric Surgery
21%
Systematic Review
21%
Glycemic Control
18%
Body Mass Index
18%
Diabetes Mellitus
17%
Clinician
16%
Maturity Onset Diabetes of the Young
16%
Patient with Diabetes
14%
Glucose
10%
Combination Therapy
10%
Inpatient
10%
Insulin Pump
10%
Insulin Treatment
10%
Retrospective Study
10%
Glucagon-Like Peptide-1 Agonist
10%
Body Weight Change
10%
Artificial Pancreas
10%
Insulin Infusion
10%
Glomerular Filtration Rate
10%
COVID-19
10%
Flushing
10%
Meta-Analysis
10%
Hospital Management
10%
Antidiabetic Agent
8%
Dipeptidyl Peptidase-4 Inhibitor
8%
Basal Body
7%
Hemoglobin A1c
5%
Sodium Glucose Cotransporter 2 Inhibitor
5%
Complications of Diabetes Mellitus
5%
Patient Preference
5%
Randomized Controlled Trial
5%
Health Care Cost
5%
Blood Glucose
5%
Pharmacology, Toxicology and Pharmaceutical Science
Hypoglycemia
97%
Insulin Dependent Diabetes Mellitus
55%
Non Insulin Dependent Diabetes Mellitus
48%
Hemoglobin A1c
28%
Insulin Degludec
21%
Antidiabetic Agent
14%
Glucagon Like Peptide 1 Receptor Agonist
12%
Liraglutide
10%
Nocturnal Hypoglycemia
10%
Chronic Kidney Failure
10%
Anemia
10%
Retrospective Study
10%
Hyperglycemia
10%
Dipeptidyl Peptidase IV Inhibitor
8%
Diabetes Mellitus
7%
Observational Study
7%
Sodium Glucose Cotransporter 2 Inhibitor
5%
Functional Status
5%
Acute Kidney Failure
5%
Randomized Controlled Trial
5%
Pandemic
5%
Adult Respiratory Distress Syndrome
5%
Infection
5%
